Catalyst Wire Dossier Catalyst Wire Dossier

Penostatin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Penostatin, covering 2017-05-18 to 2017-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies [Phase 2]

See pricing